Celltrion Pharm, Inc.
Clinical trials sponsored by Celltrion Pharm, Inc., explained in plain language.
-
Which diabetes combo works best? new study pits pioglitazone against dapagliflozin
Disease control CompletedThis study tested whether adding pioglitazone or dapagliflozin to standard diabetes pills (alogliptin and metformin) helps control blood sugar better in people with type 2 diabetes. About 133 adults with poorly controlled diabetes took one of the two combinations for 26 weeks. Th…
Phase: PHASE4 • Sponsor: Celltrion Pharm, Inc. • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
One pill to tackle two heart risks: new combo shows promise
Disease control CompletedThis study tested whether a single pill containing three medicines (ezetimibe, rosuvastatin, and amlodipine) can safely lower both cholesterol and blood pressure in Korean adults with high blood pressure and high cholesterol. 163 participants were randomly assigned to receive eit…
Phase: PHASE3 • Sponsor: Celltrion Pharm, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC